Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 374

1.

Medical cannabis and cannabinoids in rheumatology: where are we now?

Sarzi-Puttini P, Batticciotto A, Atzeni F, Bazzichi L, Di Franco M, Salaffi F, Marotto D, Ceribelli A, Ablin JN, Hauser W.

Expert Rev Clin Immunol. 2019 Sep 12. doi: 10.1080/1744666X.2019.1665997. [Epub ahead of print]

PMID:
31512536
2.

Psoriatic arthritis: from pathogenesis to pharmacologic management.

Talotta R, Atzeni F, Sarzi-Puttini P.

Pharmacol Res. 2019 Sep 7:104394. doi: 10.1016/j.phrs.2019.104394. [Epub ahead of print] Review.

PMID:
31505253
3.

Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases.

Guerrini G, Franzetti F, Giacomelli R, Meroni L, Riva A, Scirè CA, Scrivo R, Tavio M, Agostinone A, Airò P, Atzeni F, Bartalesi F, Bazzichi L, Berardicurti O, Cassola G, Castagna A, Castelli F, Cattelan A, Citriniti G, Cristini F, De Rosa F, Fracassi E, Galloway J, La Paglia GMC, Moioli MC, Ripamonti D, Saracino A, Tani C, Tascini C, Tieghi T, Tinelli M, Zabotti A, Sarzi-Puttini P, Galli M.

Clin Exp Rheumatol. 2019 Aug 27. [Epub ahead of print]

PMID:
31498077
4.

Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

Ruscitti P, Cipriani P, Liakouli V, Iacono D, Pantano I, Margiotta DPE, Navarini L, Destro Castaniti GM, Maruotti N, Di Scala G, Picciariello L, Caso F, Bongiovanni S, Grembiale RD, Atzeni F, Scarpa R, Perosa F, Emmi G, Cantatore FP, Guggino G, Afeltra A, Ciccia F, Giacomelli R.

Arthritis Res Ther. 2019 Sep 3;21(1):204. doi: 10.1186/s13075-019-1975-y.

5.

Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients.

Retamozo S, Acar-Denizli N, Rasmussen A, Horváth IF, Baldini C, Priori R, Sandhya P, Hernandez-Molina G, Armagan B, Praprotnik S, Kvarnstrom M, Gerli R, Sebastian A, Solans R, Rischmueller M, Pasoto SG, Valim V, Nordmark G, Kruize A, Nakamura H, Hofauer B, Giacomelli R, Fernandes Moça Trevisani V, Devauchelle-Pensec V, Atzeni F, Gheita TA, Consani-Fernández S, Szántó A, Sivils K, Gattamelata A, Danda D, Kilic L, Bartoloni E, Bombardieri S, Sánchez-Guerrero J, Wahren-Herlenius M, Mariette X, Ramos-Casals M, Brito-Zerón P; Sjögren Big Data Consortium.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):97-106. Epub 2019 Aug 28.

6.

Incidence, predictors and cerebrovascular consequences of leaflet thrombosis after transcatheter aortic valve implantation: a systematic review and meta-analysis.

D'Ascenzo F, Salizzoni S, Saglietto A, Cortese M, Latib A, Franzone A, Barbanti M, Nietlispach F, Holy EW, Burriesci G, De Paoli A, Fonio P, Atzeni F, Moretti C, Perl L, D'Amico M, Rinaldi M, Conrotto F.

Eur J Cardiothorac Surg. 2019 Sep 1;56(3):488-494. doi: 10.1093/ejcts/ezz099.

PMID:
31321408
7.

Noninvasive imaging methods for evaluating cardiovascular involvement in patients with rheumatoid arthritis before and after anti-TNF drug treatment.

Atzeni F, Gianturco L, Boccassini L, Sarzi-Puttini P, Bonitta G, Turiel M.

Future Sci OA. 2019 Jun 13;5(6):FSO396. doi: 10.2144/fsoa-2018-0108.

8.

The therapeutic journey of biologic agents: There will be an end?

Atzeni F, Sarzi-Puttini P.

Pharmacol Res. 2019 Sep;147:104340. doi: 10.1016/j.phrs.2019.104340. Epub 2019 Jul 2.

PMID:
31276775
9.

Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.

Ruscitti P, Cipriani P, Liakouli V, Iacono D, Pantano I, Caso F, Perosa F, Atzeni F, Cantatore FP, Scarpa R, Ciccia F, Giacomelli R.

Rheumatol Int. 2019 Jul 1. doi: 10.1007/s00296-019-04358-w. [Epub ahead of print]

PMID:
31263993
10.

Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents.

Atzeni F, Talotta R, Masala IF, Gerardi MC, Casale R, Sarzi-Puttini P.

Best Pract Res Clin Rheumatol. 2018 Aug;32(4):500-510. doi: 10.1016/j.berh.2019.02.003. Epub 2019 Feb 27. Review.

PMID:
31174819
11.

AxSpA patients who also meet criteria for fibromyalgia: identifying distinct patient clusters using data from a UK national register (BSRBR-AS).

Macfarlane GJ, Pathan E, Siebert S, Packham J, Gaffney K, Choy E, Sengupta R, Atzeni F, Martin KR, Jones GT, Dean LE.

BMC Rheumatol. 2019 May 20;3:19. doi: 10.1186/s41927-019-0066-7. eCollection 2019.

12.

Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients.

Favalli EG, Conti F, Selmi C, Iannone F, Bucci R, D'Onofrio F, Carlino G, Santo L, Semeraro A, Zuccaro C, D'Angelo S, Atzeni F, Marino F, Monti S, Guidelli GM, Spinelli FR, Biggioggero M, Caporali R.

Clin Exp Rheumatol. 2019 May 10. [Epub ahead of print]

PMID:
31074721
13.

Malar rash is a predictor of subclinical airway inflammation in patients with systemic lupus erythematosus: a pilot study.

Damiani G, Pigatto PDM, Marzano AV, Rizzi M, Santus P, Radovanovic D, Loite U, Torelli L, Petrou S, Sarzi-Puttini P, Atzeni F, Adawi M, Bridgewood C, Bragazzi NL, Watad A, Malerba M.

Clin Rheumatol. 2019 Sep;38(9):2541-2546. doi: 10.1007/s10067-019-04536-y. Epub 2019 Apr 24.

PMID:
31020473
14.

Disentangling geometrical, viscoelastic and hyperelastic effects in force-displacement relationships of folded biological tissues.

Atzeni F, Lanfranconi F, Aegerter CM.

Eur Phys J E Soft Matter. 2019 Apr 18;42(4):47. doi: 10.1140/epje/i2019-11807-x.

PMID:
31011840
15.

A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis.

Bechman K, Subesinghe S, Norton S, Atzeni F, Galli M, Cope AP, Winthrop KL, Galloway JB.

Rheumatology (Oxford). 2019 Apr 14. pii: kez087. doi: 10.1093/rheumatology/kez087. [Epub ahead of print]

PMID:
30982883
16.

Systemic rheumatic diseases: From biological agents to small molecules.

Sarzi-Puttini P, Ceribelli A, Marotto D, Batticciotto A, Atzeni F.

Autoimmun Rev. 2019 Jun;18(6):583-592. doi: 10.1016/j.autrev.2018.12.009. Epub 2019 Apr 5. Review.

PMID:
30959214
17.

Serum klotho concentrations inversely correlate with the severity of nailfold capillaroscopic patterns in patients with systemic sclerosis.

Talotta R, Rigamonti F, Letizia T, Bongiovanni S, Ditto MC, Antivalle M, Santandrea S, Atzeni F, Vago T, Sarzi-Puttini P.

Reumatismo. 2019 Apr 1;71(1):19-23. doi: 10.4081/reumatismo.2019.1129.

18.

Severe bitter taste associated with apremilast.

Damiani G, Bragazzi NL, Grossi E, Petrou S, Radovanovic D, Rizzi M, Atzeni F, Sarzi-Puttini P, Santus P, Pigatto PD, Franchi C.

Dermatol Ther. 2019 May;32(3):e12876. doi: 10.1111/dth.12876. Epub 2019 Mar 26. No abstract available.

PMID:
30882959
19.

Rationale underlying the measurement of fractional exhaled nitric oxide in systemic sclerosis patients.

Rizzi M, Radovanovic D, Airoldi A, Cristiano A, Frassanito F, Gaboardi P, Saad M, Atzeni F, Sarzi-Puttini P, Santus P.

Clin Exp Rheumatol. 2019 Feb 27. [Epub ahead of print] Review.

PMID:
30873947
20.

Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA.

Atzeni F, Sarzi-Puttini P, Sebastiani M, Panetta V, Salaffi F, Iannone F, Carletto A, Foti R, Gremese E, Govoni M, Marchesoni A, Favalli E, Gorla R, Ramonda R, Ferraccioli G, Lapadula G; GISEA group.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):649-655. Epub 2019 Feb 11.

PMID:
30767865
21.

Neuromuscular efficiency in fibromyalgia is improved by hyperbaric oxygen therapy: looking inside muscles by means of surface electromyography.

Casale R, Boccia G, Symeonidou Z, Atzeni F, Batticciotto A, Salaffi F, Sarzi-Puttini P, Brustio PR, Rainoldi A.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):75-80. Epub 2019 Feb 8.

22.

Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical study.

Atzeni F, Casale R, Alciati A, Masala IF, Batticciotto A, Talotta R, Gerardi MC, Salaffi F, Sarzi-Puttini P.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):63-69. Epub 2019 Feb 6.

PMID:
30747099
23.

One year in review 2019: fibromyalgia.

Atzeni F, Talotta R, Masala IF, Giacomelli C, Conversano C, Nucera V, Lucchino B, Iannuccelli C, Di Franco M, Bazzichi L.

Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):3-10. Epub 2019 Feb 6. Review.

24.

Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren's Syndrome through an Impaired Epigenetic Control: The State-of-The-Art.

Talotta R, Sarzi-Puttini P, Atzeni F.

J Immunol Res. 2019 Jan 6;2019:8567364. doi: 10.1155/2019/8567364. eCollection 2019. Review.

25.

Evaluation of salivary and plasma microRNA expression in patients with Sjögren's syndrome, and correlations with clinical and ultrasonographic outcomes.

Talotta R, Mercurio V, Bongiovanni S, Vittori C, Boccassini L, Rigamonti F, Batticciotto A, Atzeni F, Trabattoni D, Sarzi-Puttini P, Biasin M.

Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):70-77. Epub 2019 Jan 10.

26.

Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis.

Sebastiani M, Milazzo L, Atzeni F, Vacchi C, Manfredi A, Quartuccio L, Scirè C, Gaeta GB, Lapadula G, Armignacco O, Tavio M, D'Angelo S, Meroni P, Bazzichi L, Grassi W, Mathieu A, Mastroianni C, Sagnelli E, Santantonio T, Foppa CU, Puoti M, Sarmati L, Airò P, Epis OM, Scrivo R, Gargiulo M, Riva A, Ciancio G, Zehender G, Taliani G, Meroni L, Sollima S, Sarzi-Puttini P, Galli M.

Mod Rheumatol. 2019 Jan 22:1-8. doi: 10.1080/14397595.2018.1558918. [Epub ahead of print] Erratum in: Mod Rheumatol. 2019 Apr 2;:1.

PMID:
30582388
27.

The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts.

Favalli EG, Becciolini A, Caporali R, Todoerti M, Iannone F, Dinoia L, Sebastiani M, Spinella A, Gremese E, Cianci F, Atzeni F, Bandinelli F, Ferraccioli G, Lapadula G; GISEA Study Group.

Autoimmun Rev. 2018 Dec;17(12):1251-1258. doi: 10.1016/j.autrev.2018.07.002. Epub 2018 Oct 16. Review.

PMID:
30339886
28.

The influence of comorbidities on the efficacy of tumour necrosis factor inhibitors, and the effect of tumour necrosis factor inhibitors on comorbidities in rheumatoid arthritis: report from a National Consensus Conference.

Conti F, Atzeni F, Massaro L, Chiara Gerardi M, Gremese E, Passiu G, Carletto A, Malavolta N, Foti R, Ramonda R, Sarzi-Puttini P.

Rheumatology (Oxford). 2018 Oct 1;57(57 Suppl 7):vii11-vii22. doi: 10.1093/rheumatology/key209. Review.

PMID:
30289537
29.

Usefulness of six-minute walk test in systemic sclerosis.

Rizzi M, Radovanovic D, Santus P, Airoldi A, Frassanito F, Vanni S, Cristiano A, Sarzi-Puttini P, Atzeni F.

Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):161-167. Epub 2018 Sep 7. Review.

PMID:
30277863
30.

How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).

Brito-Zerón P, Acar-Denizli N, Ng WF, Zeher M, Rasmussen A, Mandl T, Seror R, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Armagan B, Kruize AA, Kwok SK, Kvarnström M, Praprotnik S, Sène D, Bartoloni E, Solans R, Rischmueller M, Suzuki Y, Isenberg DA, Valim V, Wiland P, Nordmark G, Fraile G, Bootsma H, Nakamura T, Giacomelli R, Devauchelle-Pensec V, Knopf A, Bombardieri M, Trevisani VF, Hammenfors D, Pasoto SG, Retamozo S, Gheita TA, Atzeni F, Morel J, Vollenveider C, Horvath IF, Sivils KL, Olsson P, De Vita S, Sánchez-Guerrero J, Kilic L, Wahren-Herlenius M, Mariette X, Ramos-Casals M; Sjögren Big Data Consortium.

Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):102-112. Epub 2018 Aug 14.

31.

Comments on "Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study".

Favalli EG, Conti F, Atzeni F, Selmi C, D'Angelo S, Caporali R, Iannone F.

J Am Acad Dermatol. 2018 Dec;79(6):e119-e120. doi: 10.1016/j.jaad.2018.07.052. Epub 2018 Aug 7. No abstract available.

PMID:
30096421
32.

Controlled-release pregabalin in the treatment of fibromyalgia.

Alciati A, Atzeni F, Masala IF, Cirillo M, Sciortino D, Perna G, Sarzi-Puttini P.

Expert Rev Neurother. 2018 Aug;18(8):617-623. doi: 10.1080/14737175.2018.1508344. Epub 2018 Aug 23. Review.

PMID:
30092164
33.

Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors.

Atzeni F, Talotta R, Nucera V, Marino F, Gerratana E, Sangari D, Masala IF, Sarzi-Puttini P.

Expert Rev Clin Immunol. 2018 Nov;14(11):945-956. doi: 10.1080/1744666X.2018.1504678. Epub 2018 Aug 21. Review. Erratum in: Expert Rev Clin Immunol. 2018 Nov;14(11):ix.

PMID:
30058434
34.

Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register.

Macfarlane GJ, MacDonald RIR, Pathan E, Siebert S, Gaffney K, Choy E, Packham J, Martin KR, Haywood K, Sengupta R, Atzeni F, Jones GT.

Rheumatology (Oxford). 2018 Nov 1;57(11):1982-1990. doi: 10.1093/rheumatology/key206.

35.

From autoinflammation to autoimmunity: old and recent findings.

Caso F, Costa L, Nucera V, Barilaro G, Masala IF, Talotta R, Caso P, Scarpa R, Sarzi-Puttini P, Atzeni F.

Clin Rheumatol. 2018 Sep;37(9):2305-2321. doi: 10.1007/s10067-018-4209-9. Epub 2018 Jul 16. Review.

PMID:
30014358
36.

A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac.

Atzeni F, Masala IF, Sarzi-Puttini P.

Pain Ther. 2018 Dec;7(2):163-177. doi: 10.1007/s40122-018-0100-2. Epub 2018 Jun 5. Review.

37.

Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series.

Talotta R, Atzeni F, Batticciotto A, Ditto MC, Gerardi MC, Sarzi-Puttini P.

J Med Case Rep. 2018 Jun 3;12(1):154. doi: 10.1186/s13256-018-1687-y.

38.

Safety of Biologics, Including Biosimilars: Perspectives on Current Status and Future Direction.

Ingrasciotta Y, Cutroneo PM, Marcianò I, Giezen T, Atzeni F, Trifirò G.

Drug Saf. 2018 Nov;41(11):1013-1022. doi: 10.1007/s40264-018-0684-9. Review.

PMID:
29796832
39.

Neurobiological similarities between RA and fibromyalgia.

Atzeni F, Sarzi-Puttini P.

Nat Rev Rheumatol. 2018 Jun;14(6):324-325. doi: 10.1038/s41584-018-0011-y. No abstract available.

PMID:
29765137
40.

Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases.

Atzeni F, Corda M, Gianturco L, Porcu M, Sarzi-Puttini P, Turiel M.

Front Med (Lausanne). 2018 Feb 14;5:26. doi: 10.3389/fmed.2018.00026. eCollection 2018. Review.

41.

Ankylosing Spondylitis Treatment after First Anti-TNF Drug Failure.

Benucci M, Damiani A, Bandinelli F, Grossi V, Infantino M, Manfredi M, Gobbi FL, Sarzi-Puttini P, Atzeni F.

Isr Med Assoc J. 2018 Feb;20(2):119-122. Review. No abstract available.

42.

The role of klotho in systemic sclerosis.

Talotta R, Bongiovanni S, Letizia T, Rigamonti F, Atzeni F, Benucci M, Vago T, Sarzi-Puttini P.

Reumatismo. 2017 Dec 21;69(4):156-163. doi: 10.4081/reumatismo.2017.987.

43.

An update on emerging drugs for fibromyalgia treatment.

Atzeni F, Gerardi MC, Masala IF, Alciati A, Batticciotto A, Sarzi-Puttini P.

Expert Opin Emerg Drugs. 2017 Dec;22(4):357-367. doi: 10.1080/14728214.2017.1418323. Epub 2017 Dec 19. Review.

PMID:
29250975
44.

Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review.

Atzeni F, Gerardi MC, Barilaro G, Masala IF, Benucci M, Sarzi-Puttini P.

Expert Rev Clin Immunol. 2018 Jan;14(1):69-82. doi: 10.1080/1744666X.2018.1411190. Epub 2017 Dec 11. Review.

PMID:
29202589
45.

Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases.

Defendenti C, Atzeni F, Malandrin S, Ardizzone S, Almasio PL, Saibeni S, Bezzio C, Bollani S, Salerno R, Declich P, Sarno Z, Bruno S, Talotta R, Sarzi-Puttini P.

Int Immunopharmacol. 2018 Jan;54:329-335. doi: 10.1016/j.intimp.2017.11.016. Epub 2017 Nov 29.

PMID:
29197269
46.

Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis.

Galli M, Antinori S, Atzeni F, Meroni L, Riva A, Scirè C, Adorni F, Quartuccio L, Sebastiani M, Airò P, Bazzichi L, Cristini F, Del Bono V, Manfredi A, Viapiana O, De Rosa F, Favalli E, Petrelli E, Salvarani C, Govoni M, Corcione S, Scrivo R, Sarmati L, Lazzarin A, Grassi W, Mastroianni C, Gaeta GB, Ferraccioli G, Cutolo M, De Vita S, Lapadula G, Matucci-Cerinic M, Armignacco O, Sarzi-Puttini P.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):1018-1028. Epub 2017 Nov 28. Review.

PMID:
29185961
47.

Are the ACR 2010 diagnostic criteria for fibromyalgia better than the 1990 criteria?

Sarzi-Puttini P, Atzeni F, Masala IF, Salaffi F, Chapman J, Choy E.

Autoimmun Rev. 2018 Jan;17(1):33-35. doi: 10.1016/j.autrev.2017.11.007. Epub 2017 Nov 3. Review.

PMID:
29108831
48.

TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?

Rubbert-Roth A, Atzeni F, Masala IF, Caporali R, Montecucco C, Sarzi-Puttini P.

Autoimmun Rev. 2018 Jan;17(1):24-28. doi: 10.1016/j.autrev.2017.11.005. Epub 2017 Nov 3. Review.

PMID:
29108829
49.

Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry.

Favalli EG, Sinigaglia L, Becciolini A, Grosso V, Gorla R, Bazzani C, Atzeni F, Sarzi Puttini PC, Fusaro E, Pellerito R, Caporali R.

Int J Rheum Dis. 2018 Feb;21(2):422-430. doi: 10.1111/1756-185X.13199. Epub 2017 Oct 30.

PMID:
29082659
50.

Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

Ruscitti P, Margiotta DPE, Macaluso F, Iacono D, D'Onofrio F, Emmi G, Atzeni F, Prete M, Perosa F, Sarzi-Puttini P, Emmi L, Cantatore FP, Triolo G, Afeltra A, Giacomelli R, Valentini G.

Medicine (Baltimore). 2017 Oct;96(42):e8180. doi: 10.1097/MD.0000000000008180.

Supplemental Content

Loading ...
Support Center